Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

India

 

Centre for Sight to IPO

The eye care chain, Centre For Sight, is the latest Indian group to publish a draft red herring prospectus as it prepares to IPO. It hopes to raise INR 115 crore (around US$ 17 million) by issuing fresh shares and existing shareholders will sell another 2.54 million shares. A million shares worth INR 60 crore (US$ 9 million) may, however, instead be placed ahead of the IPO to undisclosed investors.

Interview: Mark Britnell, Chairman and Senior Partner for the Global Health Practice, KPMG

Author of the recently published book In Search of The Perfect Health System, Mark has got through three passports in six years as he tours the world looking at healthcare systems. We talk to him about uberisation, telehealth, innovation in elderly care and the role of private healthcare providers as governments around the world roll out statutory healthcare insurance.

Apollo to enter subscription market & Malaysia

India’s largest healthcare provider, Apollo Hospitals, plans to release a subscription healthcare product in 2016. This would be the first insurance product to cover outpatient services in the country, Neeraj Garg, CEO of Apollo Health and Lifestyle, told Healthcare Nova.

Report: Private healthcare in India

India’s healthcare sector has come a long way in a short time. Total healthcare expenditure (public and private) is $70bn and growing at astonishing rates - perhaps as high as 17% CAGR. In this 4,000 word report, we look in-depth at the booming inpatient and outpatient sectors and the prospects for broadening access to private healthcare.

Narayana and Dr Lal Pathlabs to IPO within 15 days

Narayana Hrudayalaya, an Indian hospital group that focuses on cardiology, and Dr Lal Pathlabs, a pathology chain, are set to IPO within 15 days, according to the Indian press. Narayana and Dr Lal hope to raise $100 million and $90 million, respectively.

KIMS & Saket City up for grabs

The Kerala Institute of Medical Sciences (KIMS), a network of hospitals and outpatient centres in South India and the GCC, is for sale. Big national players are also eyeing up Saket City Hospitals in Delhi.

Huge market for genetic testing in India

Arranged marriages and caste separation are driving inherited disease in India, says Sam Santhosh, the CEO of MedGenome which claims to be the country’s biggest genetic laboratory group. MedGenome expects to double sales in 2015 and claims its prices are a quarter of those charged in the USA.

Exuberant international expansion

Operators in Emerging Markets are increasingly moving into other countries, often nations halfway around the world. There is a big IPO pipeline to fund all this growth. And investors like TVM Capital and Abraaj are planning massive greenfield site developments.

Shared medical appointments can supercharge productivity

How do you see 12 patients an hour instead of three patients every two hours and improve outcomes at the same time? One idea might be to take a look at shared medical appointments (SMAs). The idea is being implemented at groups from the Cleveland Clinic in the US, to Aravind Eye Hospitals in India and an NHS mental health trust in East London.

Aster DM ups stake in Saudi group Sanad Hospital to 97%

While rivals Al Noor, Mediclinic and NMC Health are engrossed in a bid war, Aster DM also wants to strengthen its presence in the Gulf states. It has bought an additional 57% stake in Saudi group Sanad Hospital, taking ownership to 97%, for $245m (AED 900m).

Find Us